DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Huntington's disease	R-HSA-1643685	0	nipecotic acid	5534	drug-path
Focal adhesion	R-HSA-354113	map04510	nipecotic acid	5534	drug-path
Axon guidance	R-HSA-422475	map04360	nipecotic acid	5534	drug-path
Olfactory transduction	R-HSA-9751605	map04740	nipecotic acid	5534	drug-path
VEGF signaling pathway	R-HSA-194138	map04370	nipecotic acid	5534	drug-path
Gap junction	R-HSA-190861	map04540	nipecotic acid	5534	drug-path
Hematopoietic cell lineage	R-HSA-173752	map04640	meteneprost	5283060	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	meteneprost	5283060	drug-path
Leukocyte transendothelial migration	R-HSA-8950732	map04670	meteneprost	5283060	drug-path
Olfactory transduction	R-HSA-9751605	map04740	meteneprost	5283060	drug-path
Cardiac muscle contraction	R-HSA-397014	map04260	meteneprost	5283060	drug-path
Cytokine-cytokine receptor interaction	R-HSA-6788467	map04060	meteneprost	5283060	drug-path
Ribosome	R-HSA-5368277	map03010	meteneprost	5283060	drug-path
Bladder cancer	R-HSA-9700206	map05219	meteneprost	5283060	drug-path
Non-small cell lung cancer	R-HSA-5619066	map05223	meteneprost	5283060	drug-path
Chronic myeloid leukemia	R-HSA-9680350	map05220	meteneprost	5283060	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	nabumetone	4409	drug-path
Adipocytokine signaling pathway	R-HSA-168638	map04920	nabumetone	4409	drug-path
Calcium signaling pathway	R-HSA-381753	map04020	nabumetone	4409	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	nabumetone	4409	drug-path